Document Classification

Section Type: RESULTS

Text: A more favorable mean change from baseline in fasting lipid profile was noted in the tenofovir DF group at week 144 : for triglyceride levels (+1 mg/dL for tenofovir DF [n = 170] vs +134 mg/dL for stavudine [n = 162], P <. 001), total cholesterol (+30 mg/dL [n = 170] vs +58 mg/dL [n = 162], P <. 001), direct low-density lipoprotein cholesterol (+14 mg/dL [n = 169] vs +26 mg/dL [n = 161], P <. 001), and high-density lipoprotein cholesterol (+9 mg/dL [n = 168] vs +6 mg/dL [n = 154], P =. 003).